Want to track CADL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Candel Therapeutics Inc. (CADL) Statistics
Valuation metrics
Market Cap 728.31M
Enterprise value 576.26M
Trailing P/E (ttm) -7.05
Forward P/E -
PEG ratio 0.09
Price/Sales (ttm) -
Price/Book (mrq) 5.84
Enterprise Value/Revenue -
Enterprise Value/EBITDA -6.93
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 876.5K
Average volume (90 days) 1.02M
Price summary
52-Week low 4.35
52-Week high 14
Beta -
50-Day moving average 10.64
200-Day moving average 7.64
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.43%
Return on equity -0.89%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.72
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 16.09%
Book value per share (mrq) 1.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
